APLS icon

Apellis Pharmaceuticals
APLS

Upgrade to unlock
Buy
Hold
Sell

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$30
27% downside
High target

10 analyst ratings

positive
4  neutral
40%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Roth Capital
Roth Capital
Adam Walsh
100% 1-yr APLS win rate
13 Mar ‘26 1 month ago
JP Morgan
JP Morgan
Anupam Rama
0% 1-yr APLS win rate
5 Mar ‘26 1 month ago
Mizuho
Mizuho
Graig Suvannavejh
5 Mar ‘26 1 month ago
Citigroup
Citigroup
Yigal Nochomovitz
60% 1-yr APLS win rate
25 Feb ‘26 1 month ago
RBC Capital
RBC Capital
Lisa Walter
25 Feb ‘26 1 month ago
Wedbush
Wedbush
Laura Chico
25 Feb ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
50% 1-yr APLS win rate
25 Feb ‘26 1 month ago
Barclays
Barclays
Eliana Merle
100% 1-yr APLS win rate
28 Jan ‘26 2 months ago
BofA Securities
BofA Securities
Tazeen Ahmad
0% 1-yr APLS win rate
21 Jan ‘26 2 months ago
Wells Fargo
Wells Fargo
Derek Archila
0% 1-yr APLS win rate
20 Jan ‘26 2 months ago